Bank of America
INTS icon

Bank of America’s Intensity Therapeutics INTS Stock Holding History

Bank of America’s Portfolio INTS Stock Details INTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23
Closed -$240 – 6288
2025
Q4 		$240 Sell
23
-2
-8% -$20 ﹤0.01% 6670
2025
Q3 		$150 Buy
25
+9
+56% +$64 ﹤0.01% 7778
2025
Q2 		$119 Buy
16
+13
+433% +$267 ﹤0.01% 7942
2025
Q1 		$124 Buy
3
+1
+50% +$56 ﹤0.01% 7795
2024
Q4 		$88 Hold
2
– – ﹤0.01% 7761
2024
Q3 		$187 Sell
2
-7
-78% -$777 ﹤0.01% 7585
2024
Q2 		$1.07K Buy
+9
New +$1.02K ﹤0.01% 7221
2024
Q1 		– Hold
0
– -$52 – 7949
2023
Q4 		– Hold
0
– – – 7495

Other funds holding INTS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SL
Sentinus LLC Oak Brook, Illinois $1.25B AUM 22.33% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America's INTS Position: Q1 2026 in Review

Bank of America sold out of Intensity Therapeutics (INTS) in Q1 2026, closing a stake of 23 shares — an estimated $240 sold.

Bank of America first reported a position in INTS in Q2 2024 and held it in 7 quarters. The position peaked at $1.07K in Q2 2024. 13 funds tracked by Wall St. Rank hold INTS as of Q1 2026.

  • Bank of America reported no remaining Intensity Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 23 Intensity Therapeutics shares in Q1 2026, an estimated $240.
  • Bank of America first reported a position in Intensity Therapeutics in Q2 2024 and held it in 7 quarters.
  • Bank of America's Intensity Therapeutics position peaked at $1.07K in Q2 2024.
  • 13 funds tracked by Wall St. Rank held Intensity Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.